Evidence map›Paper›PMID 35884388›Full record

ReviewCancers2022

The Urogenital System's Role in Diseases: A Synopsis.

Maroun Bou Zerdan, Rita Moukarzel, Nour Sabiha Naji, Yara Bilen, Arun Nagarajan

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maroun Bou ZerdanDepartment of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA.ORCID 0000-0002-9229-3079
Rita MoukarzelFaculty of Medicine, Lebanese American University Medical Center, Lebanese American University, Beirut 1102, Lebanon.
Nour Sabiha NajiFaculty of Medicine, American University of Beirut, Beirut 2020, Lebanon.
Yara BilenDepartment of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Arun NagarajanDepartment of Hematology and Oncology, Cleveland Clinic Florida, Weston, FL 33331, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human microbiota contains ten times more microbial cells than human cells contained by the human body, constituting a larger genetic material than the human genome itself. Emerging studies have shown that these microorganisms represent a critical determinant in human health and disease, and the use of probiotic products as potential therapeutic interventions to modulate homeostasis and treat disease is being explored. The gut is a niche for the largest proportion of the human microbiota with myriad studies suggesting a strong link between the gut microbiota composition and disease development throughout the body. More specifically, there is mounting evidence on the relevance of gut microbiota dysbiosis in the development of urinary tract disease including urinary tract infections (UTIs), chronic kidney disease, and kidney stones. Fewer emerging reports, however, are suggesting that the urinary tract, which has long been considered 'sterile', also houses its unique microbiota that might have an important role in urologic health and disease. The implications of this new paradigm could potentially change the therapeutic perspective in urological disease.

Indexed as

immune checkpoint inhibitormicrobiotarenal cell carcinomaurogenital system

Identifiers

PMID35884388
PMCPMC9319963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.